In situ development of an artificial intelligence (AI) model for early detection of adverse drug reactions (ADRs) to ensure drug safety

Pharmacovigilance is a vital component of public health systems, aiming to ensure the safe use of medicinal products. In this study, an artificial intelligence (AI)-based model was developed using TensorFlow to predict the likelihood of adverse drug reactions (ADRs) based on molecular structure and...

Full description

Saved in:
Bibliographic Details
Main Authors: Veselina Ruseva, Stanimir Dobrev, Violeta Getova-Kolarova, Anna Peneva, Ilko Getov, Maria Dimitrova, Valentina Petkova
Format: Article
Language:English
Published: Pensoft Publishers 2025-07-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/160997/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!